Familial retinoblastoma in developing countries

Background Although screening for familial retinoblastoma has been shown to be beneficial we suspected that such screening programs may be less than optimal in developing countries (DC). Methods Retrospective cohort study comparing patients with familial retinoblastoma from five centers in DC (Argen...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pediatric blood & cancer 2009-09, Vol.53 (3), p.338-342
Hauptverfasser: Chantada, Guillermo L., Dunkel, Ira J., Qaddoumi, Ibrahim, Antoneli, Celia B.G., Totah, Alegria, Canturk, Serife, Nawaiseh, Ibrahim, Fandiño, Adriana, Pífano, Imelda, Peksayar, Gonul, Ribeiro, Karina Braga, Abramson, David H.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 342
container_issue 3
container_start_page 338
container_title Pediatric blood & cancer
container_volume 53
creator Chantada, Guillermo L.
Dunkel, Ira J.
Qaddoumi, Ibrahim
Antoneli, Celia B.G.
Totah, Alegria
Canturk, Serife
Nawaiseh, Ibrahim
Fandiño, Adriana
Pífano, Imelda
Peksayar, Gonul
Ribeiro, Karina Braga
Abramson, David H.
description Background Although screening for familial retinoblastoma has been shown to be beneficial we suspected that such screening programs may be less than optimal in developing countries (DC). Methods Retrospective cohort study comparing patients with familial retinoblastoma from five centers in DC (Argentina, Brazil, Turkey, Jordan, and Venezuela) versus a reference center in the USA. Results Ninety‐two (32 from the USA and 60 from DC) patients were included. Forty‐one (44.6%) patients avoided enucleation, 42 (45.7%) had 1 eye removed, and 9 (9.8%) underwent bilateral enucleation. Eleven (11.9%) had major pathology risk factors at enucleation. There were no cases of metastatic disease at diagnosis. Detection via screening was significantly less common in DC than in the USA (23.3% vs. 71.8%, P 
doi_str_mv 10.1002/pbc.21970
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67503036</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67503036</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4270-68669edffd6191b19bf0de2e0fa88fb4caf8cb6fb1e1039f8b512647f5d6af4c3</originalsourceid><addsrcrecordid>eNp1kD1PwzAQQC0EoqUw8AdQJiSGtHYc28kIFQ0IBBUCdbTsxEYG5wM7AfrvCaSUieluePd0egAcIzhFEEazRubTCKUM7oAxIjEJCURsd7vDdAQOvH_pUQpJsg9GKI1xzDAcg9lClMYaYQOnWlPV0grf1qUITBUU6l3ZujHVc5DXXdU6o_wh2NPCenW0mRPwtLh8nF-Ft_fZ9fz8NszjiMGQJpSmqtC6oChFEqVSw0JFCmqRJFrGudBJLqmWSCGIU51IgiIaM00KKnSc4wk4HbyNq9865VteGp8ra0Wl6s5zygjEENMePBvA3NXeO6V540wp3JojyL_r8L4O_6nTsycbaSdLVfyRmxw9MBuAD2PV-n8TX17Mf5XhcGF8qz63F8K99i9iRvjqLuMZfrjJlnTFGf4CZLJ9yA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67503036</pqid></control><display><type>article</type><title>Familial retinoblastoma in developing countries</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Chantada, Guillermo L. ; Dunkel, Ira J. ; Qaddoumi, Ibrahim ; Antoneli, Celia B.G. ; Totah, Alegria ; Canturk, Serife ; Nawaiseh, Ibrahim ; Fandiño, Adriana ; Pífano, Imelda ; Peksayar, Gonul ; Ribeiro, Karina Braga ; Abramson, David H.</creator><creatorcontrib>Chantada, Guillermo L. ; Dunkel, Ira J. ; Qaddoumi, Ibrahim ; Antoneli, Celia B.G. ; Totah, Alegria ; Canturk, Serife ; Nawaiseh, Ibrahim ; Fandiño, Adriana ; Pífano, Imelda ; Peksayar, Gonul ; Ribeiro, Karina Braga ; Abramson, David H.</creatorcontrib><description>Background Although screening for familial retinoblastoma has been shown to be beneficial we suspected that such screening programs may be less than optimal in developing countries (DC). Methods Retrospective cohort study comparing patients with familial retinoblastoma from five centers in DC (Argentina, Brazil, Turkey, Jordan, and Venezuela) versus a reference center in the USA. Results Ninety‐two (32 from the USA and 60 from DC) patients were included. Forty‐one (44.6%) patients avoided enucleation, 42 (45.7%) had 1 eye removed, and 9 (9.8%) underwent bilateral enucleation. Eleven (11.9%) had major pathology risk factors at enucleation. There were no cases of metastatic disease at diagnosis. Detection via screening was significantly less common in DC than in the USA (23.3% vs. 71.8%, P &lt; 0.0001). Patients in DC were diagnosed at a significantly later age and with more advanced intraocular disease that led to increased risk of bilateral enucleation. Patients detected by screening in DC were significantly younger at diagnosis, had less advanced intraocular disease, better ocular preservation rates and survival results than those whose retinoblastoma was not detected via early screening. Five‐year pEFS was 0.92 for the patients treated in the USA and 0.81 for the patients in DC (P = 0.42). Seven events occurred (extraocular relapse four in patients from DC and second malignancies in three). Conclusions Patients with familial retinoblastoma are less likely to be diagnosed by screening in DC and had higher morbidity and mortality caused by recurrent extraocular retinoblastoma. Pediatr Blood Cancer 2009;53:338–342. © 2009 Wiley‐Liss, Inc.</description><identifier>ISSN: 1545-5009</identifier><identifier>EISSN: 1545-5017</identifier><identifier>DOI: 10.1002/pbc.21970</identifier><identifier>PMID: 19434730</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Child, Preschool ; Cohort Studies ; Developing Countries ; diagnosis ; familial retinoblastoma ; Humans ; Infant ; Infant, Newborn ; Retinal Neoplasms - epidemiology ; Retinal Neoplasms - mortality ; Retinoblastoma - epidemiology ; Retinoblastoma - mortality ; Retrospective Studies</subject><ispartof>Pediatric blood &amp; cancer, 2009-09, Vol.53 (3), p.338-342</ispartof><rights>Copyright © 2009 Wiley‐Liss, Inc.</rights><rights>(c) 2009 Wiley-Liss, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4270-68669edffd6191b19bf0de2e0fa88fb4caf8cb6fb1e1039f8b512647f5d6af4c3</citedby><cites>FETCH-LOGICAL-c4270-68669edffd6191b19bf0de2e0fa88fb4caf8cb6fb1e1039f8b512647f5d6af4c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fpbc.21970$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fpbc.21970$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19434730$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chantada, Guillermo L.</creatorcontrib><creatorcontrib>Dunkel, Ira J.</creatorcontrib><creatorcontrib>Qaddoumi, Ibrahim</creatorcontrib><creatorcontrib>Antoneli, Celia B.G.</creatorcontrib><creatorcontrib>Totah, Alegria</creatorcontrib><creatorcontrib>Canturk, Serife</creatorcontrib><creatorcontrib>Nawaiseh, Ibrahim</creatorcontrib><creatorcontrib>Fandiño, Adriana</creatorcontrib><creatorcontrib>Pífano, Imelda</creatorcontrib><creatorcontrib>Peksayar, Gonul</creatorcontrib><creatorcontrib>Ribeiro, Karina Braga</creatorcontrib><creatorcontrib>Abramson, David H.</creatorcontrib><title>Familial retinoblastoma in developing countries</title><title>Pediatric blood &amp; cancer</title><addtitle>Pediatr. Blood Cancer</addtitle><description>Background Although screening for familial retinoblastoma has been shown to be beneficial we suspected that such screening programs may be less than optimal in developing countries (DC). Methods Retrospective cohort study comparing patients with familial retinoblastoma from five centers in DC (Argentina, Brazil, Turkey, Jordan, and Venezuela) versus a reference center in the USA. Results Ninety‐two (32 from the USA and 60 from DC) patients were included. Forty‐one (44.6%) patients avoided enucleation, 42 (45.7%) had 1 eye removed, and 9 (9.8%) underwent bilateral enucleation. Eleven (11.9%) had major pathology risk factors at enucleation. There were no cases of metastatic disease at diagnosis. Detection via screening was significantly less common in DC than in the USA (23.3% vs. 71.8%, P &lt; 0.0001). Patients in DC were diagnosed at a significantly later age and with more advanced intraocular disease that led to increased risk of bilateral enucleation. Patients detected by screening in DC were significantly younger at diagnosis, had less advanced intraocular disease, better ocular preservation rates and survival results than those whose retinoblastoma was not detected via early screening. Five‐year pEFS was 0.92 for the patients treated in the USA and 0.81 for the patients in DC (P = 0.42). Seven events occurred (extraocular relapse four in patients from DC and second malignancies in three). Conclusions Patients with familial retinoblastoma are less likely to be diagnosed by screening in DC and had higher morbidity and mortality caused by recurrent extraocular retinoblastoma. Pediatr Blood Cancer 2009;53:338–342. © 2009 Wiley‐Liss, Inc.</description><subject>Child, Preschool</subject><subject>Cohort Studies</subject><subject>Developing Countries</subject><subject>diagnosis</subject><subject>familial retinoblastoma</subject><subject>Humans</subject><subject>Infant</subject><subject>Infant, Newborn</subject><subject>Retinal Neoplasms - epidemiology</subject><subject>Retinal Neoplasms - mortality</subject><subject>Retinoblastoma - epidemiology</subject><subject>Retinoblastoma - mortality</subject><subject>Retrospective Studies</subject><issn>1545-5009</issn><issn>1545-5017</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kD1PwzAQQC0EoqUw8AdQJiSGtHYc28kIFQ0IBBUCdbTsxEYG5wM7AfrvCaSUieluePd0egAcIzhFEEazRubTCKUM7oAxIjEJCURsd7vDdAQOvH_pUQpJsg9GKI1xzDAcg9lClMYaYQOnWlPV0grf1qUITBUU6l3ZujHVc5DXXdU6o_wh2NPCenW0mRPwtLh8nF-Ft_fZ9fz8NszjiMGQJpSmqtC6oChFEqVSw0JFCmqRJFrGudBJLqmWSCGIU51IgiIaM00KKnSc4wk4HbyNq9865VteGp8ra0Wl6s5zygjEENMePBvA3NXeO6V540wp3JojyL_r8L4O_6nTsycbaSdLVfyRmxw9MBuAD2PV-n8TX17Mf5XhcGF8qz63F8K99i9iRvjqLuMZfrjJlnTFGf4CZLJ9yA</recordid><startdate>200909</startdate><enddate>200909</enddate><creator>Chantada, Guillermo L.</creator><creator>Dunkel, Ira J.</creator><creator>Qaddoumi, Ibrahim</creator><creator>Antoneli, Celia B.G.</creator><creator>Totah, Alegria</creator><creator>Canturk, Serife</creator><creator>Nawaiseh, Ibrahim</creator><creator>Fandiño, Adriana</creator><creator>Pífano, Imelda</creator><creator>Peksayar, Gonul</creator><creator>Ribeiro, Karina Braga</creator><creator>Abramson, David H.</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200909</creationdate><title>Familial retinoblastoma in developing countries</title><author>Chantada, Guillermo L. ; Dunkel, Ira J. ; Qaddoumi, Ibrahim ; Antoneli, Celia B.G. ; Totah, Alegria ; Canturk, Serife ; Nawaiseh, Ibrahim ; Fandiño, Adriana ; Pífano, Imelda ; Peksayar, Gonul ; Ribeiro, Karina Braga ; Abramson, David H.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4270-68669edffd6191b19bf0de2e0fa88fb4caf8cb6fb1e1039f8b512647f5d6af4c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Child, Preschool</topic><topic>Cohort Studies</topic><topic>Developing Countries</topic><topic>diagnosis</topic><topic>familial retinoblastoma</topic><topic>Humans</topic><topic>Infant</topic><topic>Infant, Newborn</topic><topic>Retinal Neoplasms - epidemiology</topic><topic>Retinal Neoplasms - mortality</topic><topic>Retinoblastoma - epidemiology</topic><topic>Retinoblastoma - mortality</topic><topic>Retrospective Studies</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chantada, Guillermo L.</creatorcontrib><creatorcontrib>Dunkel, Ira J.</creatorcontrib><creatorcontrib>Qaddoumi, Ibrahim</creatorcontrib><creatorcontrib>Antoneli, Celia B.G.</creatorcontrib><creatorcontrib>Totah, Alegria</creatorcontrib><creatorcontrib>Canturk, Serife</creatorcontrib><creatorcontrib>Nawaiseh, Ibrahim</creatorcontrib><creatorcontrib>Fandiño, Adriana</creatorcontrib><creatorcontrib>Pífano, Imelda</creatorcontrib><creatorcontrib>Peksayar, Gonul</creatorcontrib><creatorcontrib>Ribeiro, Karina Braga</creatorcontrib><creatorcontrib>Abramson, David H.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Pediatric blood &amp; cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chantada, Guillermo L.</au><au>Dunkel, Ira J.</au><au>Qaddoumi, Ibrahim</au><au>Antoneli, Celia B.G.</au><au>Totah, Alegria</au><au>Canturk, Serife</au><au>Nawaiseh, Ibrahim</au><au>Fandiño, Adriana</au><au>Pífano, Imelda</au><au>Peksayar, Gonul</au><au>Ribeiro, Karina Braga</au><au>Abramson, David H.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Familial retinoblastoma in developing countries</atitle><jtitle>Pediatric blood &amp; cancer</jtitle><addtitle>Pediatr. Blood Cancer</addtitle><date>2009-09</date><risdate>2009</risdate><volume>53</volume><issue>3</issue><spage>338</spage><epage>342</epage><pages>338-342</pages><issn>1545-5009</issn><eissn>1545-5017</eissn><abstract>Background Although screening for familial retinoblastoma has been shown to be beneficial we suspected that such screening programs may be less than optimal in developing countries (DC). Methods Retrospective cohort study comparing patients with familial retinoblastoma from five centers in DC (Argentina, Brazil, Turkey, Jordan, and Venezuela) versus a reference center in the USA. Results Ninety‐two (32 from the USA and 60 from DC) patients were included. Forty‐one (44.6%) patients avoided enucleation, 42 (45.7%) had 1 eye removed, and 9 (9.8%) underwent bilateral enucleation. Eleven (11.9%) had major pathology risk factors at enucleation. There were no cases of metastatic disease at diagnosis. Detection via screening was significantly less common in DC than in the USA (23.3% vs. 71.8%, P &lt; 0.0001). Patients in DC were diagnosed at a significantly later age and with more advanced intraocular disease that led to increased risk of bilateral enucleation. Patients detected by screening in DC were significantly younger at diagnosis, had less advanced intraocular disease, better ocular preservation rates and survival results than those whose retinoblastoma was not detected via early screening. Five‐year pEFS was 0.92 for the patients treated in the USA and 0.81 for the patients in DC (P = 0.42). Seven events occurred (extraocular relapse four in patients from DC and second malignancies in three). Conclusions Patients with familial retinoblastoma are less likely to be diagnosed by screening in DC and had higher morbidity and mortality caused by recurrent extraocular retinoblastoma. Pediatr Blood Cancer 2009;53:338–342. © 2009 Wiley‐Liss, Inc.</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>19434730</pmid><doi>10.1002/pbc.21970</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1545-5009
ispartof Pediatric blood & cancer, 2009-09, Vol.53 (3), p.338-342
issn 1545-5009
1545-5017
language eng
recordid cdi_proquest_miscellaneous_67503036
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Child, Preschool
Cohort Studies
Developing Countries
diagnosis
familial retinoblastoma
Humans
Infant
Infant, Newborn
Retinal Neoplasms - epidemiology
Retinal Neoplasms - mortality
Retinoblastoma - epidemiology
Retinoblastoma - mortality
Retrospective Studies
title Familial retinoblastoma in developing countries
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T16%3A41%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Familial%20retinoblastoma%20in%20developing%20countries&rft.jtitle=Pediatric%20blood%20&%20cancer&rft.au=Chantada,%20Guillermo%20L.&rft.date=2009-09&rft.volume=53&rft.issue=3&rft.spage=338&rft.epage=342&rft.pages=338-342&rft.issn=1545-5009&rft.eissn=1545-5017&rft_id=info:doi/10.1002/pbc.21970&rft_dat=%3Cproquest_cross%3E67503036%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67503036&rft_id=info:pmid/19434730&rfr_iscdi=true